Schorno Dean L 4
4 · RIGEL PHARMACEUTICALS INC · Filed Feb 6, 2023
Insider Transaction Report
Form 4
Schorno Dean L
EVP & Chief Financial Officer
Transactions
- Sale
Common Stock
2023-02-02$1.66/sh−5,389$8,946→ 196,519 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.